KELLY SKILES: Open Payments
NPI 1396224549 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 30 payments from 16 companies in 2025. Trend: 2023 $1,297 · 2024 $1,291 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $136 |
| Novartis Pharmaceuticals Corporation | 4 | $99 |
| Incyte Corporation | 2 | $57 |
| Janssen Biotech, Inc. | 2 | $50 |
| Arcutis Biotherapeutics, Inc. | 2 | $37 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $34 |
| Galderma Laboratories, L.P. | 2 | $29 |
| UCB, Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $27 |
| LEO Pharma Inc. | 1 | $27 |
Products named: SKYRIZI, COSENTYX, OPZELURA, TREMFYA, DUPIXENT, Zoryve, Winlevi, NEMLUVIO.
Industry payments across TX — which companies pay providers there.
